Advances of Exosomal MiRNAs in Breast Cancer Progression and Diagnosis

Overview

Journal Diagnostics (Basel)

Specialty Radiology

Date 2021 Nov 27

PMID 34829498

Citations 5

Authors

Wenwen Chen

Zhongyu Li

Pengwei Deng

Zhengnan Li

Yuhai Xu

Hongjing Li

Wentao Su

Jianhua Qin

Affiliations

Soon will be listed here.

Abstract

Breast cancer is one of the most commonly diagnosed malignancies and the leading cause of cancer death in women worldwide. Although many factors associated with breast cancer have been identified, the definite etiology of breast cancer is still unclear. In addition, early diagnosis of breast cancer remains challenging. Exosomes are membrane-bound nanovesicles secreted by most types of cells and contain a series of biologically important molecules, such as lipids, proteins, and miRNAs, etc. Emerging evidence shows that exosomes can affect the status of cells by transmitting substances and messages among cells and are involved in various physiological and pathological processes. In breast cancer, exosomes play a significant role in breast tumorigenesis and progression through transfer miRNAs which can be potential biomarkers for early diagnosis of breast cancer. This review discusses the potential utility of exosomal miRNAs in breast cancer progression such as tumorigenesis, metastasis, immune regulation and drug resistance, and further in breast cancer diagnosis.

Citing Articles

Exosomes Secreted by Wharton's Jelly-Derived Mesenchymal Stem Cells Promote the Ability of Cell Proliferation and Migration for Keratinocyte.

Yu H, Huang H, Chen I, Li S Int J Mol Sci. 2024; 25(9).

PMID: 38731977 PMC: 11084911. DOI: 10.3390/ijms25094758.

The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application.

Munoz J, Perez-Moreno P, Perez Y, Calaf G Diagnostics (Basel). 2023; 13(19).

PMID: 37835815 PMC: 10572677. DOI: 10.3390/diagnostics13193072.

Harnessing cancer stem cell-derived exosomes to improve cancer therapy.

Yang J, Teng Y J Exp Clin Cancer Res. 2023; 42(1):131.

PMID: 37217932 PMC: 10204319. DOI: 10.1186/s13046-023-02717-x.

Non-Coding RNAs Modulating Estrogen Signaling and Response to Endocrine Therapy in Breast Cancer.

Treeck O, Haerteis S, Ortmann O Cancers (Basel). 2023; 15(6).

PMID: 36980520 PMC: 10046587. DOI: 10.3390/cancers15061632.

Oxidative-Induced Angiogenesis Is Modulated by Small Extracellular Vesicle miR-302a-3p Cargo in Retinal Pigment Epithelium Cells.

Oltra M, Martinez-Santos M, Ybarra M, Rowland H, Muriach M, Romero J Antioxidants (Basel). 2022; 11(5).

PMID: 35624680 PMC: 9137950. DOI: 10.3390/antiox11050818.

References

Ribeiro M, Zhu H, Millard R, Fan G . Exosomes Function in Pro- and Anti-Angiogenesis. Curr Angiogenes. 2014; 2(1):54-59. PMC: 4217212. DOI: 10.2174/22115528113020020001. View

Ni Q, Stevic I, Pan C, Muller V, Oliveira-Ferrer L, Pantel K . Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients. Sci Rep. 2018; 8(1):12974. PMC: 6113263. DOI: 10.1038/s41598-018-31108-y. View

Kia V, Paryan M, Mortazavi Y, Biglari A, Mohammadi-Yeganeh S . Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells. J Cell Biochem. 2018; 120(4):5666-5676. DOI: 10.1002/jcb.27850. View

Skog J, Wurdinger T, van Rijn S, Meijer D, Gainche L, Sena-Esteves M . Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10(12):1470-6. PMC: 3423894. DOI: 10.1038/ncb1800. View

Brody J, Rudel R, Maxwell N, Swedis S . Mapping out a search for environmental causes of breast cancer. Public Health Rep. 1996; 111(6):494-507. PMC: 1381895. View

Yu S, Wei Y, Xu Y, Zhang Y, Li J, Zhang J . Extracellular vesicles in breast cancer drug resistance and their clinical application. Tumour Biol. 2016; 37(3):2849-61. DOI: 10.1007/s13277-015-4683-5. View

Zhao Y, Jin L, Zhang X . Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1. Aging (Albany NY). 2021; 13(14):18498-18514. PMC: 8351670. DOI: 10.18632/aging.203298. View

Bao G, Rhee W, Tsourkas A . Fluorescent probes for live-cell RNA detection. Annu Rev Biomed Eng. 2009; 11:25-47. PMC: 2734976. DOI: 10.1146/annurev-bioeng-061008-124920. View

Han M, Hu J, Lu P, Cao H, Yu C, Li X . Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer. Cell Death Dis. 2020; 11(1):43. PMC: 6976584. DOI: 10.1038/s41419-020-2250-5. View

10.

Li M, Zou X, Xia T, Wang T, Liu P, Zhou X . A five-miRNA panel in plasma was identified for breast cancer diagnosis. Cancer Med. 2019; 8(16):7006-7017. PMC: 6853814. DOI: 10.1002/cam4.2572. View

11.

Wang Y, Zhou J, Chen Y, Wang C, Wu E, Fu L . Quantification of distinct let-7 microRNA family members by a modified stem-loop RT-qPCR. Mol Med Rep. 2017; 17(3):3690-3696. PMC: 5802175. DOI: 10.3892/mmr.2017.8297. View

12.

Jung K, Youn H, Lee C, Kang K, Chung J . Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells. Oncotarget. 2016; 8(6):9899-9910. PMC: 5354779. DOI: 10.18632/oncotarget.14247. View

13.

Chen W, Xu L, Qian Q, He X, Peng W, Fan W . d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission. Biosci Rep. 2018; 38(5). PMC: 6165836. DOI: 10.1042/BSR20180110. View

14.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

15.

Stevic I, Muller V, Weber K, Fasching P, Karn T, Marme F . Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial. BMC Med. 2018; 16(1):179. PMC: 6178264. DOI: 10.1186/s12916-018-1163-y. View

16.

Chen W, Cao R, Su W, Zhang X, Xu Y, Wang P . Simple and fast isolation of circulating exosomes with a chitosan modified shuttle flow microchip for breast cancer diagnosis. Lab Chip. 2021; 21(9):1759-1770. DOI: 10.1039/d0lc01311k. View

17.

Muluhngwi P, Klinge C . Roles for miRNAs in endocrine resistance in breast cancer. Endocr Relat Cancer. 2015; 22(5):R279-300. PMC: 4563344. DOI: 10.1530/ERC-15-0355. View

18.

Cummings M, Simpson P, Reid L, Jayanthan J, Skerman J, Song S . Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol. 2013; 232(1):23-31. PMC: 4288974. DOI: 10.1002/path.4288. View

19.

Wei Y, Li M, Cui S, Wang D, Zhang C, Zen K . Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes. Molecules. 2016; 21(6). PMC: 6274101. DOI: 10.3390/molecules21060777. View

20.

Zou X, Xia T, Li M, Wang T, Liu P, Zhou X . MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis. Cancer Biomark. 2020; 30(1):41-53. DOI: 10.3233/CBM-201547. View